LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)
Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
Royalty Pharma reports first quarter 2026 results
NRG Energy Reports First Quarter 2026 Results and Reaffirms 2026 Financial Guidance
The New York Times Company Reports First-Quarter 2026 Results
Tonix Pharmaceuticals Secures Commercial Payer Coverage forTONMYA®, Providing Access for ~35 Million U.S. Patients
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany
The Kraft Heinz Company Declares Regular Quarterly Dividend of $0.40 Per Share
Immunocore reports first quarter financial results and provides a business update
Insulet - Insulet Reports First Quarter 2026 Results
908 Devices Inc. - 908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio